MAINA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 19.696
EU - Europa 17.801
AS - Asia 6.468
SA - Sud America 682
OC - Oceania 327
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 61
Totale 45.183
Nazione #
US - Stati Uniti d'America 19.025
IT - Italia 6.332
CN - Cina 3.511
IE - Irlanda 1.946
FR - Francia 1.601
DE - Germania 1.356
SE - Svezia 1.152
UA - Ucraina 1.096
KR - Corea 965
FI - Finlandia 947
GB - Regno Unito 910
PL - Polonia 606
CA - Canada 502
VN - Vietnam 405
ES - Italia 384
BR - Brasile 337
JP - Giappone 316
IN - India 289
AU - Australia 277
NL - Olanda 266
TR - Turchia 223
RU - Federazione Russa 219
SG - Singapore 159
TW - Taiwan 158
BE - Belgio 155
MX - Messico 134
CH - Svizzera 133
PT - Portogallo 104
GR - Grecia 103
CL - Cile 100
RO - Romania 100
DK - Danimarca 97
AT - Austria 95
HK - Hong Kong 94
CO - Colombia 78
AR - Argentina 67
ID - Indonesia 62
EU - Europa 58
IR - Iran 53
NZ - Nuova Zelanda 50
EC - Ecuador 45
PE - Perù 43
TH - Thailandia 43
IL - Israele 41
NO - Norvegia 40
EG - Egitto 35
ZA - Sudafrica 34
PK - Pakistan 25
RS - Serbia 24
HU - Ungheria 20
HR - Croazia 18
MY - Malesia 18
NG - Nigeria 18
LT - Lituania 17
TN - Tunisia 17
PH - Filippine 16
LK - Sri Lanka 15
SI - Slovenia 15
IS - Islanda 14
CR - Costa Rica 13
CZ - Repubblica Ceca 12
SA - Arabia Saudita 12
SK - Slovacchia (Repubblica Slovacca) 10
MA - Marocco 9
BG - Bulgaria 8
IQ - Iraq 8
LB - Libano 8
BA - Bosnia-Erzegovina 7
BD - Bangladesh 6
GT - Guatemala 6
KE - Kenya 6
NP - Nepal 6
AL - Albania 5
MO - Macao, regione amministrativa speciale della Cina 5
MU - Mauritius 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
PR - Porto Rico 4
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
QA - Qatar 3
SN - Senegal 3
UZ - Uzbekistan 3
A1 - Anonimo 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CU - Cuba 2
KG - Kirghizistan 2
KW - Kuwait 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RE - Reunion 2
SC - Seychelles 2
Totale 45.156
Città #
Beijing 2.458
Houston 2.234
Chandler 2.187
Dublin 1.926
Villeurbanne 896
Jacksonville 885
Fairfield 860
Ashburn 803
Medford 649
Ann Arbor 603
Princeton 603
Wilmington 545
Redwood City 542
Woodbridge 528
Torino 522
Warsaw 495
Milan 459
Seattle 407
Nyköping 385
Cambridge 312
Dearborn 306
Rome 258
Pisa 254
Turin 244
Boston 243
Dong Ket 199
Boardman 134
Toronto 130
Verona 109
Shanghai 101
Nanjing 99
Norwalk 96
Taipei 95
Ottawa 89
Tokyo 85
Des Moines 82
Brussels 74
Singapore 74
Guangzhou 70
London 69
Hefei 68
New York 64
Fremont 63
Piemonte 61
Florence 58
Santiago 58
Hangzhou 57
Vienna 57
San Diego 56
Padova 55
Bologna 54
Falls Church 53
São Paulo 53
Amsterdam 49
Helsinki 49
Istanbul 48
Palermo 47
Chengdu 45
Madrid 45
Sydney 43
Lachine 41
Kunming 40
Central District 38
Los Angeles 38
Paris 38
Pune 37
Jinan 36
Seoul 36
Naples 35
Philadelphia 35
Bari 34
Wuhan 34
Zhengzhou 34
Sudbury 32
Barcelona 31
Chicago 31
Gainesville 31
Nanchang 31
Changsha 30
Melbourne 30
Perugia 30
Jakarta 29
Bangkok 28
Catania 28
Washington 28
Dallas 27
Mountain View 27
Raritan 27
Athens 26
Lima 26
Phoenix 26
Aarhus 25
Berlin 25
Buenos Aires 25
Genoa 25
Hamburg 25
Medellín 25
San Mateo 25
Central 24
Genova 24
Totale 23.410
Nome #
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. 2.560
Trattamento con litio e potenziali effetti collaterali a lungo termine: una revisione sistematica della letteratura 1.435
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 845
Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. 734
Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder 575
Paliperidone palmitate and metabolic syndrome in patients with schizophrenia a 12-month observational prospective cohort study 551
Involuntary admissions in Italy: the impact of seasonality 441
Disturbi bipolari e d’ansia: aspetti epidemiologici e clinici. 426
Lithium-associated hyperparathyroidism and hypercalcaemia: A case-control cross-sectional study 423
Gender-related distribution of personality disorders in a sample of patients with panic disorder. 412
Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women. 398
Increased uric acid levels in bipolar disorder subjects during different phases of illness. 371
Affective recurrences in bipolar disorder after switching from lithium to valproate or vice versa: A series of 57 cases 370
Glucose metabolism alterations in patients with bipolar disorder. 344
Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions 343
Duloxetina e bupropione in pazienti con disturbo depressivo maggiore resistente agli SSRI 342
A randomized, single-blind comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression 338
Combining drug and psychological treatments for obsessive-compulsive disorder: What is the evidence, when and for whom 335
Il temperamento ciclotimico nei pazienti con DOC. 332
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 306
High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder 294
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 279
Sindrome metabolica e disturbi psichiatrici: confronto tra disturbo bipolare e disturbo ossessivo-compulsivo 278
Metabolic syndrome and Obsessive-Compulsive Disorder: a naturalistic Italian study 278
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. 274
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder 273
Anti-brain antibodies in adult patients with obsessive-compulsive disorder 263
Anticorpi anti-SNC in adulti con disturbo ossessivo-compulsivo 262
Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. 261
Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase 252
Brief dynamic therapy and depression severity: a single-blind, randomized study. 250
General Medical Conditions Are Associated With Delay to Treatment in Patients with Bipolar Disorder. 248
Mania mista e antidepressivi: uno studio clinico su un campione di pazienti ricoverati per disturbo bipolare 245
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: A case-control study 227
The role of the potassium channel gene KCNK2 in major depressive disorder 222
Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study 217
Obsessive-compulsive disorder and cyclothymic temperament: an exploration of clinical features 216
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression 215
Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates 214
Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: Long-term results 205
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 205
Cyclothymic temperament and major depressive disorder: A study on Italian patients 197
The use of antidepressants in bipolar disorder 188
Terapia farmacologica della distimia: uno studio di confronto fra amisulpride, fluoxetina e lorazepam 180
Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study. 179
Il disturbo ossessivo-compulsivo di personalità (DOCP): prevalenza nei pazienti con disturbi d'ansia e nei soggetti sani 177
Diagnostic delay in ADHD: Duration of untreated illness and its socio-demographic and clinical predictors in a sample of adult outpatients 171
Efficacia e tollerabilità della Lofepramina nel trattamento della depressione nel paziente ambulatoriale 168
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. 152
Bipolar disorders: is there an influence of seasonality or photoperiod? 151
Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. 148
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 144
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 143
Disturbo ossessivo-compulsivo sottosoglia 143
Differenze di genere nel disturbo ossessivo-compulsivo: uno studio clinico su 415 pazienti. 143
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy. 143
Paziente ricoverato per episodio maniacale : trattamento con asenapina in acuto e nel lungo termine 142
Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire. 141
Disturbo ossessivo-compulsivo con concomitanti disturbi da uso di sostanze: uno studio clinico 139
L’inquadramento nosografico dei disturbi dell’umore: dai sintomi alla diagnosi, dalla diagnosi alla terapia. 139
Combined treatments in obsessive-compulsive disorder: current knowledge and future prospects. 138
Can quetiapine extended release (ER) induce labial edema in a female patient with treatment-resistant major depressive episode? 138
L’intervento psicoeducazionale multifamiliare (IPM) nel disturbo ossessivo-compulsivo: uno studio pilota 136
Il disturbo ossessivo-compulsivo. Epidemiologia e clinica. 129
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia. 128
Tecniche di stimolazione cerebrale nel trattamento della depressione resistente [Brain stimulation therapies for treatment-resistant depression]. 128
Early childhood infections, antistreptococcal and basal ganglia antibodies in adult ADHD: a preliminary study 128
Gender related differences in the onset of panic disorder 127
Impact of comorbid obsessive-compulsive disorder on suicidality in patients with bipolar disorder 126
La stimolazione del nervo vago (VNS) nel trattamento della depressione maggiore resistente: risultati preliminari di uno studio clinico sperimentale spontaneo 125
Correlates of violent suicide attempts in patients with bipolar disorder 125
The Impact of General Medical Conditions in Obsessive-Compulsive Disorder 123
Episodic and chronic obsessive-compulsive disorder. 121
L’intervento psicoeducazionale multifamiliare nel disturbo ossessivo-compulsivo 119
Common and specific blood microRNA alterations in unipolar and bipolar depression 119
Effectiveness of cognitive-behavioural therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study. 114
Hoarding e disturbo ossessivo-compulsivo (DOC): due entità cliniche distinte in comorbilità o hoarding secondario al DOC? 112
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 111
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder 110
Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences 109
Psychiatric and physical rehabilitation intensive approach for suicide attempters by jumping from heights 109
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 108
A 10-year evaluation on adolescents with anxiety disorders: are they at risk of bipolarity? 107
Fenomenologia del paziente con disturbo ossessivo-compulsivo ad esordio precoce e ad esordio in età adulta 105
Studio clinico sperimentale spontaneo sul trattamento della depressione maggiore resistente mediante stimolezione del nervo vago: risultati a due anni di follow-up 102
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia. 100
[Generalized anxiety disorder. Clinical and nosological remarks] 99
L’influenza della comorbidità con disturbo bipolare sulla clinica del disturbo ossessivo-compulsivo 99
Definizione e strategie terapeutiche della depressione resistente al trattamento: una revisione della letteratura 99
Validità ed affidabilità del Quality of Life, Enjoyment and Satisfaction Questionnaire, versione breve 99
Trattamento farmacologico con sali di litio in pazienti affetti da disturbo bipolare: cosa succede al metabolismo del calcio? 98
Ansia e disturbo bipolare: comorbilità o epifenomeno? 97
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context 97
[The general practitioner and psychiatric assistance. A study carried out in the Piedmont region] 92
La comorbidità del disturbo ossessivo-compulsivo con i disturbi di asse I: differenza tra i sessi e correlazione con il decorso clinico 92
Brief dynamic therapy combined with pharmacotherapy in the treatment of panic disorder with concurrent depressive symptoms. 92
Il disturbo ossessivo compulsivo 91
L'ipotesi autoimmune nel disturbo ossessivo-compulsivo: studio immunologico su un campione di pazienti adulti 91
Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness 91
A 5-year follw-up evaluation of adolescents with anxiety disorders: are they at risk of bipolarity? 90
Totale 24.471
Categoria #
all - tutte 111.369
article - articoli 0
book - libri 0
conference - conferenze 29.427
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.313 0 0 0 0 0 0 0 0 0 0 980 333
2019/20207.419 330 363 529 738 529 1.647 756 512 758 420 460 377
2020/20216.052 583 299 560 345 502 432 746 299 673 489 456 668
2021/20225.262 307 252 326 303 326 255 364 378 348 276 712 1.415
2022/20238.374 891 545 335 730 702 2.143 710 556 749 243 487 283
2023/20244.032 492 665 277 349 343 488 273 397 84 417 247 0
Totale 46.941